摘要
抗有丝分裂物质结合中在秋水仙素的微管蛋白抗是重要的抗肿瘤和血管破坏剂。吡啶类和吖嗪在药物化学是是享有特权的支架,并且近年来许多秋水仙碱站点配体(CSL)已将其纳入到自己的结构以提高其药代动力学和药效学性质的目的。秋水仙碱站点配体已根据它们的化学结构和含有抗肿瘤化合物吡啶和吡啶化学结构分类进行了描述。还讨论了结构修饰背后的设计原则和取得的夹杂在这些杂环化合物其生物活性效果。吸取成就和失败的经验教训,并为描绘出未来的观点。
关键词: 吖嗪、吡啶、抗有丝分裂物质,微管蛋白,秋水仙碱、抗肿瘤、药物设计。
Current Medicinal Chemistry
Title:Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Volume: 23 Issue: 11
Author(s): R. Álvarez, L. Aramburu, P. Puebla, E. Caballero, M. González, A. Vicente, M. Medarde, R. Peláez
Affiliation:
关键词: 吖嗪、吡啶、抗有丝分裂物质,微管蛋白,秋水仙碱、抗肿瘤、药物设计。
摘要: Antimitotics binding at the colchicine site of tubulin are important antitumour and vascular disrupting agents. Pyridines and azines are privileged scaffolds in medicinal chemistry and in recent years many colchicine site ligands (CSL) have incorporated them into their structures with the aim of improving their pharmacokinetic and pharmacodynamics properties. CSL have been classified according to their chemical structures and the chemical structures of the pyridine and azine containing antimitotic compounds are described. The designed principles behind the structural modifications and the achieved effect on the biological activity upon inclusion of these heterocycles are also discussed. Lessons from the achievements and failures have been extracted and future perspectives delineated.
Export Options
About this article
Cite this article as:
R. Álvarez, L. Aramburu, P. Puebla, E. Caballero, M. González, A. Vicente, M. Medarde, R. Peláez , Pyridine Based Antitumour Compounds Acting at the Colchicine Site, Current Medicinal Chemistry 2016; 23 (11) . https://dx.doi.org/10.2174/092986732311160420104823
DOI https://dx.doi.org/10.2174/092986732311160420104823 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Glioblastoma Problem: Targeting by Combined Medicinal Chemistry Approaches
Current Medicinal Chemistry Analysis of Microarray Gene Expression Data
Current Bioinformatics Strategies for the Preparation of Bifunctional Gadolinium(III) Chelators
Current Organic Synthesis The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Current Neuropharmacology MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types
Current Cancer Drug Targets Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Endothelial Progenitor Cells: Hope Beyond Controversy
Current Cancer Drug Targets Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters Angiogenesis-Related Cytokines in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Progress in Drug Treatment of Cerebral Edema
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Current Drug Targets Targeting Cancer Stem Cells: Promises and Challenges
Anti-Cancer Agents in Medicinal Chemistry Bone Regeneration and Repair
Current Stem Cell Research & Therapy A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Current Medicinal Chemistry Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine <sup>90</sup>Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical
Current Radiopharmaceuticals The Functions of Heparanase in Human Diseases
Mini-Reviews in Medicinal Chemistry